Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP543464.RA6re6ucprm7maeO8hOYYLqFGgIHXXeC1liSteI1NF68Q130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP543464.RA6re6ucprm7maeO8hOYYLqFGgIHXXeC1liSteI1NF68Q130_assertion type Assertion NP543464.RA6re6ucprm7maeO8hOYYLqFGgIHXXeC1liSteI1NF68Q130_head.
- NP543464.RA6re6ucprm7maeO8hOYYLqFGgIHXXeC1liSteI1NF68Q130_assertion description "[These results suggest that efatutazone inhibits cell motility by antagonizing the TGF-?/Smad2 pathway and effectively prevents metastasis in NSCLC patients with acquired resistance to EGFR-TKI regardless of the resistance mechanism.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP543464.RA6re6ucprm7maeO8hOYYLqFGgIHXXeC1liSteI1NF68Q130_provenance.
- NP543464.RA6re6ucprm7maeO8hOYYLqFGgIHXXeC1liSteI1NF68Q130_assertion evidence source_evidence_literature NP543464.RA6re6ucprm7maeO8hOYYLqFGgIHXXeC1liSteI1NF68Q130_provenance.
- NP543464.RA6re6ucprm7maeO8hOYYLqFGgIHXXeC1liSteI1NF68Q130_assertion SIO_000772 24698130 NP543464.RA6re6ucprm7maeO8hOYYLqFGgIHXXeC1liSteI1NF68Q130_provenance.
- NP543464.RA6re6ucprm7maeO8hOYYLqFGgIHXXeC1liSteI1NF68Q130_assertion wasDerivedFrom befree-20150227 NP543464.RA6re6ucprm7maeO8hOYYLqFGgIHXXeC1liSteI1NF68Q130_provenance.
- NP543464.RA6re6ucprm7maeO8hOYYLqFGgIHXXeC1liSteI1NF68Q130_assertion wasGeneratedBy ECO_0000203 NP543464.RA6re6ucprm7maeO8hOYYLqFGgIHXXeC1liSteI1NF68Q130_provenance.